Position in NVS
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$207,810
+$6,028 QoQ
Shares Held
1,326
+0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,302
of 1,603 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Everhart Financial Group, Inc. holds $28,655,287 across 10 Drug Manufacturers - General names. NVS ranks #10 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,990 | $9,583,446 | |
| 2 | ABBV |
AbbVie Inc.
|
25,328 | $6,373,537 | |
| 3 | JNJ |
Johnson & Johnson
|
18,334 | $4,656,285 | |
| 4 | MRK |
Merck & Co., Inc.
|
19,484 | $2,503,694 | |
| 5 | AMGN |
Amgen Inc
|
5,085 | $1,841,380 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
9,646 | $1,218,675 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
21,040 | $1,212,324 | |
| 8 | PFE |
Pfizer Inc
|
27,433 | $660,586 |
All Filings in NVS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $207,810 | 1,326 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $201,782 | 1,321 | Shares | Sole | 2026-04-09 | |
| No filing history on record for this holder in this stock. | ||||||